In light of the ongoing and evolving situation with Covid-19, we at Magna Laboratories are fully committed to the protection our staff, patients and wider community that we serve. With this in mind, we will be continuing to provide our services, however we will be making amendments to our processes to minimise contact between our staff whilst continuing to provide our normal services. Magna Laboratories does not envisage that there will be any significant disruption to the testing service.

We believe utilising the technology at our disposal at this time, will help ensure continuity of our services as more people are working remotely. Currently many sites receive plasma assay results via the postal network, switching to email (via secure NHSmail) could help improve communication between Magna Laboratories and healthcare professionals wherever they may work. To change the delivery method of results, a request to change can be sent to, additional recipients can be included with the permission of the named consultant or pharmacist.

More information about clozapine (Zaponex®) can be found via the ZTAS website (, the ZTAS advice relating to care of clozapine patients during the Covid-19 pandemic in contained in this document.